Evidence map›Paper›PMID 35444545›Full record

ArticleFrontiers in pharmacology2022

Extraction Optimization, Structural Characterization, and Anti-Hepatoma Activity of Acidic Polysaccharides From

Wenwen Su, Leilei Wu, Qichao Liang, Xiaoyue Lin, Xiaoyi Xu, Shikai Yu, Yitong Lin, Jiadong Zhou, Yang Fu, Xiaoyan Gao and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Modulation of Antitumor Immunity and the Tumor Microenvironment byInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. A Comprehensive Review ofDrug design, development and therapy · 2026
    Review
  5. Article
  6. Protective effects ofCytotechnology · 2025
    Article
  7. Review
  8. Review
  9. Research Progress ofIntegrative cancer therapies
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Wenwen SuDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Leilei WuCollage of Pharmacology, Mudanjiang Medical University, Mudanjiang, China.
Qichao LiangCollage of Pharmacology, Mudanjiang Medical University, Mudanjiang, China.
Xiaoyue LinThe First Clinical College of Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Xiaoyi XuThe First Clinical College of Medicine, Mudanjiang Medical University, Mudanjiang, China.
Shikai YuCollage of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Yitong LinDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Jiadong ZhouCollage of Basic Medicine, Mudanjiang Medical University, Mudanjiang, China.
Yang FuDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Xiaoyan GaoDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Bo ZhangDepartment of Oncology, Mudanjiang Cancer Hospital, Mudanjiang, China.
Li LiCollage of Basic Medicine, Mudanjiang Medical University, Mudanjiang, China.
Dan LiDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Yongkui YinCollege of Life Sciences, Mudanjiang Medical University, Mudanjiang, China.
Gaochen SongDepartment of Biochemistry and Molecular Biology, Mudanjiang Medical University, Mudanjiang, China.
Mudanjiang Medical University · CNBeijing National Laboratory for Molecular Sciences · CNAffiliated Hospital of Liaoning University of Traditional Chinese Medicine · CNHeilongjiang University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Chinese medicinal herb

Indexed as

anti-hepatoma activitypolysaccharidespurificationScutellaria barbata D. Donstructure

Identifiers

PMID35444545
PMCPMC9014130
OpenAlexW4226287791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.